Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma (Q40534845)
Jump to navigation
Jump to search
scientific article published on July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma |
scientific article published on July 2004 |
Statements
1 reference
Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma (English)
1 reference
Ann Richmond
1 reference
Katayoun I Amiri
1 reference
Linda W Horton
1 reference
Bonnie J LaFleur
1 reference
Jeffrey A Sosman
1 reference
1 July 2004
1 reference
1 reference
4912-4918
1 reference
Identifiers
1 reference